Diane E. Wilfong - 10 Dec 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: SVP, Controller & CAO
Signature: /s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Issuer symbol: GILD
Transactions as of: 10 Dec 2022
Net transactions value: -$13,108
Form type: 4
Filing time: 13 Dec 2022, 14:15:22 UTC
Previous filing: 10 Nov 2022
Next filing: 26 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+318	+1.1%		28,651	10 Dec 2022	Direct	F1
transaction	GILD	Common Stock	Tax liability	$13,108	-149	-0.52%	$87.97	28,502	10 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-318	-2.4%		12,924	10 Dec 2022	Common Stock	318		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.